The Peripheral Peril: Injected Insulin Induces Insulin Insensitivity in Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Abstract
Insulin resistance is an underappreciated facet of type 1 diabetes that occurs with remarkable consistency and considerable magnitude. Although therapeutic innovations are continuing to normalize dysglycemia, a sizable body of data suggests a second metabolic abnormality—iatrogenic hyperinsulinemia—principally drives insulin resistance and its consequences in this population and has not been addressed. We review this evidence to show that injecting insulin into the peripheral circulation bypasses first-pass hepatic insulin clearance, which leads to the unintended metabolic consequence of whole-body insulin resistance. We propose restructuring insulin therapy to restore the physiological insulin balance between the hepatic portal and peripheral circulations and thereby avoid the complications of life-long insulin resistance. As technology rapidly advances and our ability to ensure euglycemia improves, iatrogenic insulin resistance will become the final barrier to overcome to restore normal physiology, health, and life in type 1 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In fact, the improvement of glycemic control through SC insulin delivery does not come without a cost: individuals with T1D are exposed to peripheral nonphysiologic hyperinsulinemia that, over time, is a major contributor to macrovascular complications, including heart failure and macrovascular disease”
From Developing the UVA/Padova Type 1 Diabetes Simulator: Modeling, Validation, Refinements, and Utility (2023) · cites this paper as [139]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“that are still 3 times more frequent in those with T1D respect to their healthy peers (see Gregory 139 also for pertinent literature review).”
From Developing the UVA/Padova Type 1 Diabetes Simulator: Modeling, Validation, Refinements, and Utility (2023) · cites this paper as [139]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Immunoassay of endogenous plasma insulin in man
Yalow, R. S., & Berson, S. A. (1960) · Journal of Clinical Investigation · doi:10.1172/jci104130 · Cited by 3,041
Glycemic Control and Excess Mortality in Type 1 Diabetes
Lind, M., Svensson, A.-M., Kosiborod, M., Gudbjörnsdottir, S., Pivodic, A., Wedel, H., Dahlqvist, S., Clements, M., & Rosengren, A. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408214 · Cited by 964
Berson, S. A., Yalow, R. S., Bauman, A., Rothschild, M. A., & Newerly, K. (1956) · Journal of Clinical Investigation · doi:10.1172/jci103262 · Cited by 836
Insulin Resistance and Hyperinsulinemia
Shanik, M. H., Xu, Y., Škrha, J., Dankner, R., Zick, Y., & Roth, J. (2008) · Diabetes Care · doi:10.2337/dc08-s264 · Cited by 791
The Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group (2016) · Diabetes Care · doi:10.2337/dc15-1990 · Cited by 712
The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes
Wilkin, T. J. (2001) · Diabetologia · doi:10.1007/s001250100548 · Cited by 623 · cited 1×
“” These concepts posit that coexisting b-cell immune intolerance and insulin resistance related to increased weight work in concert to accelerate b-cell loss and thwart insulin therapy in type 1 diabetes (68,69).”
BackgroundWeinzimer, S. A., Steil, G. M., Swan, K. L., Dziura, J., Kurtz, N., & Tamborlane, W. V. (2008) · Diabetes Care · doi:10.2337/dc07-1967 · Cited by 567
DeFronzo, R. A., Simonson, D., & Ferrannini, E. (1982) · Diabetologia · doi:10.1007/bf00253736 · Cited by 541
Orchard, T. J., Olson, J. C., Erbey, J. R., Williams, K., Forrest, K. Y.-Z., Smithline Kinder, L., Ellis, D., & Becker, D. J. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1374 · Cited by 492 · cited 1×
“Epidemiologic data from the Pittsburgh Epidemiology of Diabetes Complications study (21) and observational data from the Coronary Artery Calcification in Type 1 Diabetes (CACTI) study (13,22) have linked insulin resistance independently with cardiovascular disease, which remains the major lifelimiting complication of…”
MethodProinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood.
Horwitz, D. L., Starr, J. I., Mako, M. E., Blackard, W. G., & Rubenstein, A. H. (1975) · Journal of Clinical Investigation · doi:10.1172/jci108047 · Cited by 473 · cited 1×
“By the mid-1970s, additional investigations in canines (6) and humans (7,8) demonstrated that hepatic clearance maintained insulin at two- to threefold higher levels in the portal circulation than in the peripheral circulation.”
BackgroundIMMUNOASSAY OF ENDOGENOUS PLASMA INSULIN IN MAN
YALOW, R. S., & BERSON, S. A. (1996) · Obesity Research · doi:10.1002/j.1550-8528.1996.tb00274.x · Cited by 460
Himsworth, H. P. (1936) · The Lancet · doi:10.1016/s0140-6736(01)36134-2 · Cited by 441
Insulin Resistance is a Prominent Feature of Insulin-dependent Diabetes
DeFronzo, R. A., Hendler, R., & Simonson, D. (1982) · Diabetes · doi:10.2337/diab.31.9.795 · Cited by 365
Del Prato, S., Leonetti, F., Simonson, D. C., Sheehan, P., Matsuda, M., & DeFronzo, R. A. (1994) · Diabetologia · doi:10.1007/bf00400466 · Cited by 322 · cited 2×
“(37) later conducted two studies to quantify and localize the defect in insulin action following chronic, sustained hyperinsulinemia and hyperglycemia in healthy volunteers.”
BackgroundNadeau, K. J., Regensteiner, J. G., Bauer, T. A., Brown, M. S., Dorosz, J. L., Hull, A., Zeitler, P., Draznin, B., & Reusch, J. E. B. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1756 · Cited by 309
Natural Course of Insulin Resistance in Type I Diabetes
Yki-Järvinen, H., & Koivisto, V. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198607243150404 · Cited by 304
Production of insulin resistance by hyperinsulinaemia in man
Rizza, R. A., Mandarino, L. J., Genest, J., Baker, B. A., & Gerich, J. E. (1985) · Diabetologia · doi:10.1007/bf00279918 · Cited by 293
Corkey, B. E. (2012) · Diabetes · doi:10.2337/db11-1483 · Cited by 285
Dabelea, D., Kinney, G., Snell-Bergeon, J. K., Hokanson, J. E., Eckel, R. H., Ehrlich, J., Garg, S., Hamman, R. F., & Rewers, M. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2833 · Cited by 250
Portal and Peripheral Vein Immunoreactive Insulin Concentrations Before and After Glucose Infusion
Blackard, W. G., & Nelson, N. C. (1970) · Diabetes · doi:10.2337/diab.19.5.302 · Cited by 247
Henry, R. R., Rosenstock, J., Edelman, S., Mudaliar, S., Chalamandaris, A.-G., Kasichayanula, S., Bogle, A., Iqbal, N., List, J., & Griffen, S. C. (2015) · Diabetes Care · doi:10.2337/dc13-2955 · Cited by 238
Insulin resistance in type 1 diabetes: what is ‘double diabetes’ and what are the risks?
Cleland, S. J., Fisher, B. M., Colhoun, H. M., Sattar, N., & Petrie, J. R. (2013) · Diabetologia · doi:10.1007/s00125-013-2904-2 · Cited by 238
Schauer, I. E., Snell-Bergeon, J. K., Bergman, B. C., Maahs, D. M., Kretowski, A., Eckel, R. H., & Rewers, M. (2011) · Diabetes · doi:10.2337/db10-0328 · Cited by 230 · cited 3×
“, BMI, waist circumference, triglyceridemia) inversely correlated with insulin sensitivity among type 1 diabetes participants as expected, this relationship was effectively “left-shifted” for the type 1 diabetes participants compared with the control participants (13).”
BackgroundMethodHyperglycemia Decreases Glucose Uptake in Type I Diabetes
Yki-Järvinen, H., Helve, E., & Koivisto, V. A. (1987) · Diabetes · doi:10.2337/diab.36.8.892 · Cited by 205
Insulin's direct effects on the liver dominate the control of hepatic glucose production
Edgerton, D. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27073 · Cited by 196
Perseghin, G., Lattuada, G., Danna, M., Sereni, L. P., Maffi, P., De Cobelli, F., Battezzati, A., Secchi, A., Del Maschio, A., & Luzi, L. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00279.2003 · Cited by 187
Insulin resistance in type 1 diabetes mellitus
Kaul, K., Apostolopoulou, M., & Roden, M. (2015) · Metabolism · doi:10.1016/j.metabol.2015.09.002 · Cited by 176
A causal role for hyperinsulinemia in obesity
Templeman, N. M., Skovsø, S., Page, M. M., Lim, G. E., & Johnson, J. D. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0449 · Cited by 168 · cited 1×
“Research by several leading investigators suggests hyperinsulinemia per se may exacerbate, sustain, and even initiate obesity and insulin insensitivity in the metabolic syndrome and type 2 diabetes (27,66,67).”
BackgroundPieber, T. R., Famulla, S., Eilbracht, J., Cescutti, J., Soleymanlou, N., Johansen, O. E., Woerle, H. J., Broedl, U. C., & Kaspers, S. (2015) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12494 · Cited by 166
Prevalence of Hepatic Steatosis After Islet Transplantation and Its Relation to Graft Function
Bhargava, R., Senior, P. A., Ackerman, T. E., Ryan, E. A., Paty, B. W., Lakey, J. R. T., & Shapiro, A. M. J. (2004) · Diabetes · doi:10.2337/diabetes.53.5.1311 · Cited by 161
Reduced Circulating Insulin Enhances Insulin Sensitivity in Old Mice and Extends Lifespan
Templeman, N. M., Flibotte, S., Chik, J. H. L., Sinha, S., Lim, G. E., Foster, L. J., Nislow, C., & Johnson, J. D. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.048 · Cited by 148
Samols, E., & Ryder, J. A. (1961) · Journal of Clinical Investigation · doi:10.1172/jci104435 · Cited by 140
Kaden, M., Harding, P., & Field, J. B. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107386 · Cited by 132
Antonetti, D. A., Reynet, C., & Kahn, C. R. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117790 · Cited by 122
Donga, E., Dekkers, O. M., Corssmit, E. P. M., & Romijn, J. A. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0911 · Cited by 121
Continuous Subcutaneous Insulin Infusion Therapy Decreases Insulin Resistance in Type 1 Diabetes*
YKI-JÄRVINEN, H., & KOIVISTO, V. A. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-58-4-659 · Cited by 118
Yki-Järvinen, H., DeFronzo, R. A., & Koivisto, V. A. (1984) · Diabetes Care · doi:10.2337/diacare.7.6.520 · Cited by 112
Diabetes Mellitus: Its differentiation into insulin-sensitive and insulin-insensitive types
Himsworth, H. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dyt203 · Cited by 112
Marangou, A. G., Weber, K. M., Boston, R. C., Aitken, P. M., Heggie, J. C. P., Kirsner, R. L. G., Best, J. D., & Alford, F. P. (1986) · Diabetes · doi:10.2337/diab.35.12.1383 · Cited by 111
Vuorinen-Markkola, H., Koivisto, V. A., & Yki-Jarvinen, H. (1992) · Diabetes · doi:10.2337/diab.41.5.571 · Cited by 109
Features of Hepatic and Skeletal Muscle Insulin Resistance Unique to Type 1 Diabetes
Bergman, B. C., Howard, D., Schauer, I. E., Maahs, D. M., Snell-Bergeon, J. K., Eckel, R. H., Perreault, L., & Rewers, M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3172 · Cited by 107
The kinetics of peritoneal insulin absorption
Schade, D. S., Eaton, R. P., Davis, T. M. E., Akiya, F., Phinney, E. S., Kubica, R., Vaughn, E. A., & Day, P. W. (1981) · Metabolism · doi:10.1016/0026-0495(81)90164-5 · Cited by 97
Cree-Green, M., Newcomer, B. R., Brown, M. S., Baumgartner, A. D., Bergman, B., Drew, B., Regensteiner, J. G., Pyle, L., Reusch, J. E. B., & Nadeau, K. J. (2015) · Diabetes · doi:10.2337/db14-0765 · Cited by 94
Dassau, E., Renard, E., Place, J., Farret, A., Pelletier, M., Lee, J., Huyett, L. M., Chakrabarty, A., Doyle, F. J., & Zisser, H. C. (2017) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12999 · Cited by 94
Clinical Trial of Programmable Implantable Insulin Pump For Type I Diabetes
Selam, J.-L., Micossi, P., Dunn, F. L., Nathan, D. M., & Implantable Insulin Pump Trial Study Group (1992) · Diabetes Care · doi:10.2337/diacare.15.7.877 · Cited by 92
Liu, H.-Y., Cao, S. Y., Hong, T., Han, J., Liu, Z., & Cao, W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.016675 · Cited by 91
Perseghin, G., Lattuada, G., COBELLI, F. D., Esposito, A., Costantino, F., Canu, T., Scifo, P., Taddeo, F. D., Maffi, P., Secchi, A., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-0014-5 · Cited by 89
Mortimore, G. E., & Tietze, F. (1959) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1959.tb44913.x · Cited by 87
Crowther, G. J., Milstein, J. M., Jubrias, S. A., Kushmerick, M. J., Gronka, R. K., & Conley, K. E. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00343.2002 · Cited by 86
Lager, I., Lönnroth, P., von Schenck, H., & Smith, U. (1983) · BMJ · doi:10.1136/bmj.287.6406.1661 · Cited by 85
Novel PEGylated Basal Insulin LY2605541 Has a Preferential Hepatic Effect on Glucose Metabolism
Moore, M. C., Smith, M. S., Sinha, V. P., Beals, J. M., Michael, M. D., Jacober, S. J., & Cherrington, A. D. (2014) · Diabetes · doi:10.2337/db13-0826 · Cited by 84
Self-citationLiebl, A., Hoogma, R., Renard, E., Geelhoed‐Duijvestijn, P. H. L. M., Klein, E., Diglas, J., Kessler, L., Melki, V., Diem, P., Brun, J. ‐., et al. (2009) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01059.x · Cited by 83
Buse, J. B., Rodbard, H. W., Trescoli Serrano, C., Luo, J., Ivanyi, T., Bue-Valleskey, J., Hartman, M. L., Carey, M. A., & Chang, A. M. (2016) · Diabetes Care · doi:10.2337/dc15-1531 · Cited by 82
Dynamics of Insulin Secretion in Hypoglycemia
Yalow, R. S., & Berson, S. A. (1965) · Diabetes · doi:10.2337/diab.14.6.341 · Cited by 80
Carpentier, A., Patterson, B. W., Uffelman, K. D., Giacca, A., Vranic, M., Cattral, M. S., & Lewis, G. F. (2001) · Diabetes · doi:10.2337/diabetes.50.6.1402 · Cited by 71
Madison, L. L., Combes, B., Unger, R. H., & Kaplan, N. M. (1959) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1959.tb39579.x · Cited by 69
Improved Glycemic Control With Intraperitoneal Versus Subcutaneous Insulin in Type 1 Diabetes
Logtenberg, S. J., Kleefstra, N., Houweling, S. T., Groenier, K. H., Gans, R. O., van Ballegooie, E., & Bilo, H. J. (2009) · Diabetes Care · doi:10.2337/dc08-2340 · Cited by 68
Effect of a glucagon receptor antibody (REMD‐477) in type 1 diabetes: A randomized controlled trial
Pettus, J., Reeds, D., Cavaiola, T. S., Boeder, S., Levin, M., Tobin, G., Cava, E., Thai, D., Shi, J., Yan, H., et al. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13202 · Cited by 67
Shishko, P. I., Kovalev, P. A., Goncharov, V. G., & Zajarny, I. U. (1992) · Diabetes · doi:10.2337/diab.41.9.1042 · Cited by 63
Gregory, J. M., Smith, T. J., Slaughter, J. C., Mason, H. R., Hughey, C. C., Smith, M. S., Kandasamy, B., Greeley, S. A. W., Philipson, L. H., Naylor, R. N., et al. (2019) · Diabetes · doi:10.2337/db19-0324 · Cited by 63
Self-citationYouth With Type 1 Diabetes Have Adipose, Hepatic, and Peripheral Insulin Resistance
Cree-Green, M., Stuppy, J. J., Thurston, J., Bergman, B. C., Coe, G. V., Baumgartner, A. D., Bacon, S., Scherzinger, A., Pyle, L., & Nadeau, K. J. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00433 · Cited by 61
Edgerton, D. S., Scott, M. F., Farmer, B., Williams, P. E., Madsen, P., Kjeldsen, T., Brand, C. L., Fledelius, C., Nishimura, E., & Cherrington, A. D. (2019) · JCI Insight · doi:10.1172/jci.insight.126974 · Cited by 61
Self-citationHenry, R. R., Mudaliar, S., Ciaraldi, T. P., Armstrong, D. A., Burke, P., Pettus, J., Garhyan, P., Choi, S. L., Jacober, S. J., Knadler, M. P., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0210 · Cited by 58
Kacerovsky, M., Brehm, A., Chmelik, M., Schmid, A. I., Szendroedi, J., Kacerovsky-Bielesz, G., Nowotny, P., Lettner, A., Wolzt, M., Jones, J. G., et al. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02298.x · Cited by 57
Improved Insulin Sensitivity in Patients with Type I Diabetes Mellitus After CSII
Simonson, D. C., Tamborlane, W. V., Sherwin, R. S., Smith, J. D., DeFronzo, R. A., & The Kroc Collaborative Study Group (1985) · Diabetes · doi:10.2337/diab.34.3.s80 · Cited by 51
Haardt, M.-J., Selam, J.-L., Slama, G., Bethoux, J.-P., Dorange, C., Mace, B., Ramaniche, M.-L., & Bruzzo, F. (1994) · Diabetes Care · doi:10.2337/diacare.17.8.847 · Cited by 49
Bergenstal, R. M., Lunt, H., Franek, E., Travert, F., Mou, J., Qu, Y., Antalis, C. J., Hartman, M. L., Rosilio, M., Jacober, S. J., et al. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12698 · Cited by 47
Blevins, T., Pieber, T. R., Colón Vega, G., Zhang, S., Bastyr, E. J., Chang, A. M., & on behalf of the IMAGINE 4 Investigators (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12696 · Cited by 45
van Dijk, P. R., Logtenberg, S. J. J., Gans, R. O. B., Bilo, H. J. G., & Kleefstra, N. (2014) · Clinical Endocrinology · doi:10.1111/cen.12546 · Cited by 44
Gregory, J. M., Kraft, G., Scott, M. F., Neal, D. W., Farmer, B., Smith, M. S., Hastings, J. R., Allen, E. J., Donahue, E. P., Rivera, N., et al. (2015) · Diabetes · doi:10.2337/db15-0071 · Cited by 44
Self-citationEffect of Chronic Hyperglycemia on Glucose Metabolism in Subjects With Normal Glucose Tolerance
Shannon, C. E., Merovci, A., Xiong, J., Tripathy, D., Lorenzo, F., McClain, D. A., Abdul-Ghani, M. A., Norton, L., & DeFronzo, R. A. (2018) · Diabetes · doi:10.2337/db18-0439 · Cited by 44
Meier, J. J., Hong-McAtee, I., Galasso, R., Veldhuis, J. D., Moran, A., Hering, B. J., & Butler, P. C. (2006) · Diabetes · doi:10.2337/db06-0069 · Cited by 43
Donga, E., van Dijk, M., Hoogma, R. P. L. M., Corssmit, E. P. M., & Romijn, J. A. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2343 · Cited by 42
Jacober, S. J., PRINCE, M. J., Beals, J. M., Hartman, M. L., Qu, Y., Linnebjerg, H., Garhyan, P., & Haupt, A. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12744 · Cited by 40
Hyperinsulinemia in transgenic mice carrying multiple copies of the human insulin gene
Marbán, S. L., DeLoia, J. A., & Gearhart, J. D. (1989) · Developmental Genetics · doi:10.1002/dvg.1020100503 · Cited by 34
Improvement in Insulin Sensitivity After Human Islet Transplantation for Type 1 Diabetes
Rickels, M. R., Kong, S. M., Fuller, C., Dalton-Bakes, C., Ferguson, J. F., Reilly, M. P., Teff, K. L., & Naji, A. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1764 · Cited by 34
Marbán, S. L., & Roth, J. (1996) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4612-4112-6_13 · Cited by 32
Perkins, B. A., Cherney, D. Z. I., Soleymanlou, N., Lee, J. A., Partridge, H., Tschirhart, H., Zinman, B., Mazze, R., Fagan, N., Kaspers, S., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0141085 · Cited by 32
Complications of continuous intraperitoneal insulin infusion with an implantable pump
van Dijk, P. R., Logtenberg, S. J., Groenier, K. H., Haveman, J. W., Kleefstra, N., & Bilo, H. J. (2012) · World Journal of Diabetes · doi:10.4239/wjd.v3.i8.142 · Cited by 29
Khedkar, A., Lebovitz, H. E., Fleming, A., Cherrington, A. D., Jose, V. M., Athalye, S. N., & Vishweswaramurthy, A. (2019) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.730 · Cited by 27
Self-citationKlonoff, D. C., Bode, B. W., Cohen, N., Penn, M. S., Geho, W. B., & Muchmore, D. B. (2019) · Diabetes Care · doi:10.2337/dc19-0152 · Cited by 24
Item, F., Heinzer-Schweizer, S., Wyss, M., Fontana, P., Lehmann, R., Henning, A., Weber, M., Boesiger, P., Boutellier, U., & Toigo, M. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00747.2010 · Cited by 22
Rodrigues, T. D. C., Biavatti, K., de Almeida, F. K., & Gross, J. L. (2010) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2010007500109 · Cited by 22
Chakrabarty, A., Gregory, J. M., Moore, L. M., Williams, P. E., Farmer, B., Cherrington, A. D., Lord, P., Shelton, B., Cohen, D., Zisser, H., et al. (2019) · Journal of Process Control · doi:10.1016/j.jprocont.2019.01.002 · Cited by 21
Self-citationIntraportal hyperinsulinemia decreases insulin-stimulated glucose uptake in the dog
McGuinness, O. P., Friedman, A., & Cherrington, A. D. (1990) · Metabolism · doi:10.1016/0026-0495(90)90064-j · Cited by 20
Self-citationMudaliar, S. R. D., Henry, R. R., Ciaraldi, T. P., Armstrong, D. A., Burke, P., Pettus, J., Garhyan, P., Choi, S. L., Knadler, M. P., Lam, E. C. Q., et al. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12753 · Cited by 20
Nunez, D. J., & D’Alessio, D. A. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13102 · Cited by 19
Gregory, J. M., Lautz, M., Moore, L. M., Williams, P. E., Reddy, P., & Cherrington, A. D. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13498 · Cited by 19
Self-citationDietary Carbohydrate, a Big Mac, and Insulin Requirements in Type I Diabetes
Vlachokosta, F. V., Piper, C. M., Gleason, R. E., Kinzel, L. S., & Kahn, C. R. (1988) · Diabetes Care · doi:10.2337/diacare.11.4.330 · Cited by 16
Adjunctive Treatments for Type 1 Diabetes
Nathan, D. M. (2017) · New England Journal of Medicine · doi:10.1056/nejme1711296 · Cited by 15
Gregory, J. M., Kraft, G., Scott, M. F., Neal, D. W., Farmer, B., Smith, M. S., Hastings, J. R., Madsen, P., Kjeldsen, T., Hostrup, S., et al. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13808 · Cited by 14
Self-citation1565-P: Gender Differences in Clinical Predictors of Nonalcoholic Steatohepatitis in Type 2 Diabetes
Panicker, S., & Stephens, J. W. (2019) · Diabetes · doi:10.2337/db19-1565-p · Cited by 4
Research works printed but not linked: 1
- Valcarce, 2019, Results from the sentinel and learning phase of the Simplici-T1 study, the first clinical trial to test activation of glucokinase as an adjunctive treatment for type 1 diabetes, Diabetologia, 62, 1
Cited by
Hyperinsulinemia in Obesity, Inflammation, and Cancer
Zhang, A. M. Y., Wellberg, E. A., Kopp, J. L., & Johnson, J. D. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0250 · Cited by 305
ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Insulin delivery
Sherr, J. L., Schoelwer, M., Dos Santos, T. J., Reddy, L., Biester, T., Galderisi, A., van Dyk, J. C., Hilliard, M. E., Berget, C., & DiMeglio, L. A. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13421 · Cited by 152
Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance
Apostolopoulou, M., Lambadiari, V., Roden, M., & Dimitriadis, G. D. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnae032 · Cited by 90
Insulin resistance in cardiovascular disease, uremia, and peritoneal dialysis
Lambie, M., Bonomini, M., Davies, S., Accili, D., Arduini, A., & Zammit, V. A. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.06.001 · Cited by 90
Diabetes pathogenesis and management: the endothelium comes of age
Love, K. M., Barrett, E. J., Malin, S. K., Reusch, J. E. B., Regensteiner, J. G., & Liu, Z. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjab024 · Cited by 57
Metadata
- Authors
- Gregory, J. M., Cherrington, A. D., & Moore, D. J.
- Affiliations
- Vanderbilt University (US)
- Corresponding author
- Gregory, Justin M.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2020-04-13
- Volume
- 69
- Issue
- 5
- Pages
- 837-847
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC7171956
- OpenAlex
- W3016704539
- Cited by
- 76
- References
- 93
- Citations by year
- 2026: 10 · 2025: 15 · 2024: 11 · 2023: 5 · 2022: 23 · 2021: 9 · 2020: 3
- FWCI
- 1.53
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (K12HD087023)
- Wallace Family Fund in Diabetes Research
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- type 1 diabetes, insulin resistance, insulin therapy, hepatic insulin clearance, normoglycemia
- MeSH terms
- Animals, Diabetes Mellitus, Type 1, Gene Expression Regulation, Humans, Insulin, Insulin Resistance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.